PIPELINE
  • Indication
    • Uveitis (macular edema associated with uveitis)

      Diabetic Macular Edema

    • Progressive Myopia

    • Presbyopia

    • Corneal endothelial dysfunction

    • Dry Eye

    • Glaucoma

  • Commercial Rights
    • Greater China & South Korea

    • Greater China & South Korea

    • Greater China & South Korea

    • Greater China & South Korea

    • Greater China, South Korea, ASEAN countries

    • Global

  • Partners
    • Preclinical
    • Phase I
    • Phase II
    • Phase III / Pivotal Study
    • NDA / Regulatory Approval
    • Marketed
    • US
      US
    • US
    • US
    • JP
    • US
    • *
    Arctic Vision China R&D Progress Partners R&D Progress
ADDRESS
Suite 906-908, 9F, Tower II, Century Link, 1196 Century Avenue, Shanghai, China
SUBSCRIBE TO OUR NEWSLETTER
Subscribe
Copyright © 2020 Arctic Vision (Shanghai) Biotechnology Co., Ltd.